In today’s changing healthcare environment, the role of patient advocacy is evolving.
Biopharmaceutical companies are taking great measures to include the voice of the patient in all aspects of the drug development process – from pre-clinical testing through commericalization. This event will bring together a panel of patient advocates to discuss how these companies are making efforts to engage patients earlier in the drug development and communication process and to share strategies and results from initiatives taken at different biopharma companies.
We would like to invite you to join us on June 18th, 2014 from 5:30 pm to 8:00 pm for a unique opportunity to learn more about the changing landscape of patient advocacy.
The event will include a networking session and a moderated panel discussion followed by a Q & A.
We’d like to thank Millennium: The Takeda Oncology Company for sponsoring this event.
Faraz Ali, Vice President, Head of Program Management and Commercial Development, Bluebird Bio
Mike Walsh, Associate Director, Advocacy Relations, Biogen IDEC
Dan Leonard, Senior Manager, Patient Advocacy, Genzyme
Kathy Gram, Director, Corporate Communications,
Millennium: The Takeda Oncology Company
When: Wednesday, June 18th, 5:30-8:00 PM
Where: Millennium: The Takeda Oncology Co., Cambridge MA
There will be appetizers and beverages provided. Parking space and free Wifi will be available.
Tickets: General public: $15 in advance; $20 at the door; as a benefit of being a BYHP member you will receive an access code via email as well as the first 15 Millennium employees to register for free.
If you have any questions about this event please contact email@example.com
Interested in becoming a BYHP member to enjoy events like this one for free? Please apply for membership and an access code will be extended to you via email.
Send this to a friend